The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
| Image |  |
|---|---|
| Description | scientific article published on May 2006 |
| Author/s |
author: Adele Carotenuto Manuela Campiglio Antonella De Luca Monica Rosaria Maiello Mario Mancino Sylvie Menard Nicola Normanno |
| Publication date | May 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |